Clinicopathological Study of Non – Immune

Thrombocytopenia by Balaji, P M
CLINICOPATHOLOGICAL STUDY OF NON 
IMMUNE THROMBOCYTOPENIA
Dissertation submitted in partial  fulfillment of the
requirements  for the degree of
M.D. (PATHOLOGY) 
BRANCH - III
GOSCHEN INSTITUTE OF PATHOLOGY
MADRAS MEDICAL COLLEGE 
CHENNAI.
THE TAMILNADU
DR.M.G.R.MEDICAL UNIVERSITY
CHENNAI
MARCH 2010
222
CERTIFICATE
This  is  to  certify  that  this  dissertation  entitled 
“CLINICOPATHOLOGICAL  STUDY  OF  NON  –  IMMUNE 
THROMBOCYTOPENIA” is  a  bonafide  work  done  by 
Dr.P.M.BALAJI, in  partial  fulfillment  of  the  requirements  of  
THE TAMIL NADU DR.M.G.R. MEDICAL UNIVERSITY, Chennai for 
the award of  M.D. Pathology Degree.
DIRECTOR                                     GUIDE
Prof. Dr. A.SUNDARAM, M.D.,                                       
Director and Head,
Institute of Pathology, 
Madras Medical College,
Chennai – 600 003. 
DEAN
Prof.Dr.J.MOHANA SUNDARAM, .M.D., D.N.B. Ph.D.,
Madras Medical College & Government  General  Hospital,
Chennai – 600 003.
Prof. Dr.GEETHA DEVADAS, M.D., D.C.P.
Professor of Pathology,
Institute of Pathology ,
Madras Medical College,
Chennai – 600003.
DECLARATION
I  declare  that  this  dissertation  entitled 
“CLINICOPATHOLOGICAL  STUDY  OF  NON  –  IMMUNE 
THROMBOCYTOPENIA” has been done by me under the guidance 
and supervision of  Prof. Dr.GEETHA DEVADAS, M.D., D.C.P.  It is 
submitted in partial fulfillment of the requirements for the award of the 
M.D.  Pathology  degree  by  The  Tamilnadu  Dr.  M.G.R.  Medical 
University, Chennai. This has not been submitted by me for the award of 
any degree or diploma from any other University. 
Dr.P.M.BALAJI
444
ACKNOWLEDGEMENT
I  express  my  sincere  thanks  to  Prof.Dr.J.MOHANA 
SUNDARAM, M.D., D.N.B., Ph.D., Dean, Madras Medical College and 
Government General Hospital, for allowing me to utilize the facilities of 
the Institution.
I  am  extremely  grateful  to  Prof.  Dr.  A.SUNDARAM  M.D., 
Director  and  Head,  Institute  of  Pathology  and  Electron  Microscopy, 
Madras  Medical  College  and  Government  General  Hospital,  for  his 
constant encouragement and support.
I express my sincere gratitude to Prof. Dr.GEETHA DEVADAS, 
M.D.,  D.C.P.,  Professor  of  Pathology, Institute  of   Pathology,  Madras 
Medical  College  and  Government  General  Hospital,  for  her  valuable 
efforts, guidance and inspiration throughout this study.
I  would  like  to  express  my  special  thanks  to  Prof. 
Dr.P.KARKUZHALI  M.D., Professor  of  Pathology,  Institute  of 
Pathology, Madras Medical College and Government General Hospital, 
for her valuable support  throughout this study.
           I express my special thanks to Prof. Dr.SUDHA VENKATESH, 
M.D., Professor of Pathology, Institute of  Pathology, Madras Medical 
College  and  Government  General  Hospital,  for  her  valuable  support 
throughout this study.
            I am grateful to Prof. Dr.S.PAPPATHI M.D.,D.C.H., Professor 
of  Pathology,  Institute  of   Pathology,  Madras  Medical  College  and 
Government General Hospital, for her valuable support during this study.
I express my unfeigned thanks to Prof. Dr.T.B.UMADEVI, M.D., 
Professor  of  Pathology,  Institute  of  Child  Health,  Madras  Medical 
College  and  Government  General  Hospital,  for  her  valuable  support 
throughout this study.
          I  wish to record my heartfelt  thanks to  Prof.Dr.SHANTHA 
RAVISANKAR M.D.,D.C.P.,   Professor of Neuropathology, Institute of 
Neurology, Madras Medical College and Government General Hospital, 
for her valuable suggestions  throughout this study.
          I express my sincere thanks to Prof. Dr.K.RAMA M.D., Professor 
of Pathology, Govt. Kasturba Gandhi Hospital, Madras Medical College 
for her valuable support  throughout this study.
           I express my deep gratitude to Prof. Dr.M.P.KANCHANA, M.D., 
Professor  of  Pathology,  Institute  of  Obstetrics  & Gynecology,  Madras 
Medical  College  and  Government  General  Hospital,  for  her  valuable 
guidance and healthy criticism throughout this study.  
I  express  my  sincere  thanks  to  Prof.  Dr.T.CHITRA,  M.D., 
Professor  of  Pathology,  Regional  Institute of   Ophthalmology, Madras 
Medical  College  and  Government  General  Hospital,  for  her  valuable 
support  throughout this study.            
I wish to express my gratitude to Prof. Dr. Pragna B.Dolia, M.D. 
Director and Head, Institute of Biochemistry, Madras Medical College 
and  Government  General  Hospital,  for  her  continuous  support  and 
guidance throughout the study. 
I  wish  to  thank  all  the   Assistant  Professors  of  the  Institute  of 
Pathology, Madras Medical College and Government General Hospital, 
for their continuous support.
I would not like to miss thanking all my colleagues, friends and the 
technical staff to whom I am indebted for their valuable time, generous 
support and motivation without which this study project would not have 
seen the light. 
666
I also express my gratitude to all the  patients  who were subjects 
of this study for their cooperation.
Words are not enough to thank my family and all my well wishers 
for their understanding, moral support and constant encouragement.
Lastly,  never  the  least,  I  thank  God  and  each  and  everyone 
mentioned or not, who have extended a helping hand.
LIST OF ABBREVIATIONS
SLE       Systemic Lupus Erythematosis
AML      Acute Myeloid Leukemia
ALL        Acute Lymphoblastic leukemia
PT          Prothrombin time
APTT      Activated partial thromboplastin time
LDH        Lactate dehydrogenase
DIC        Disseminated intravascular coagulation
CML       Chronic myeloid leukemia
MDS       Myelodysplastic syndrome
ANA     Antinuclear antibody
ACLA   Anti Cardiolipin antibody
 
888
CONTENTS
S.NO
.
                      TITLE PAGE NO.
1 INTRODUCTION 1
2 AIMS AND OBJECTIVES 2
3 REVIEW OF LITERATURE 3
4 MATERIALS AND METHODS 29
5 RESULTS 36
6 DISCUSSION 39
7 SUMMARY & CONCLUSION 50
BIBLIOGRAPHY
MASTER CHART
ANNEXURES
INTRODUCTION
Thrombocytopenia  may  be  defined  as  a  subnormal  number  of 
platelets in the circulating blood ie less than 150 x 109/L. 
It is the most common cause of abnormal bleeding. The causes of 
thrombocytopenia are diverse but they can be grouped according to the 
distribution by an immne or non immune mechanism or requestration of 
platelets. 
Pseudothrombocytopenia  also  should  be  considered  in  the 
differential diagnosis  particularly in asymptomatic patients and results 
from invitro clumping of platelets following blood collection. 
The differential  diagnosis  of thrombocytopenia in adult  is  broad 
but is acquired in the vast majority of patients, usually associated with an 
underlying  disease  or  because  of  an  auto  immune  process.  A large 
number adult patients are diagnosed incidentally  on routine examination 
careful examination o the blood film is the bes means for narrowing the 
differential diagnosis. 
This  prospective  study focuses  on the  analysis  of  adult  patients 
confirmed with thrombocytopenia using clinical and relevant laboratory 
parameters to assure at a possible aetiopathogenesis. 
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AIMS AND OBJECTIVES
1. To  evaluate  patients  with  thrombocytopenia  presenting  to  the 
clinical pathology, medical OP and haematology OP departments 
of Government General Hospital and Madras Medical College.
2. To  evaluate  those  patients  with  thrombocytopenia  in  whom 
additional pathogenetic mechanisms were suspected.
REVIEW OF LITERATURE
Megakaryopoiesis and Thrombopoiesis
Each  day  the  adult  human  produces  approximately  1x1011 
platelets,which can increase 10 to 20 fold in times of increased demand.
Production  of  platelets  depends  on  the  proliferation  and 
differentiation  of  haematopoietic  stem  and  progenitor  cells  to  a  cell 
committed  to  the  megakaryocytic  lineage,  its  maturation  to  a  large 
polyploid megakaryocyte and its final fragmentation into platelets.
A supportive marrow stroma consisting of  endothelial  and other 
cells, matrix glyosaminoglycans and a family of protein hormones and 
cytokines  including  thrombopoietin,stem  cell  factor,IL-6,IL-11  and 
stromal  cell  derived  factor  I  are  the  external  factors  that  impact 
megakaryopoiesis and thrombopoiesis.
The maturation stages of the megakaryocyte include:
Megakaryoblast     Basophilic megakaryocyte     Granular megakaryocyte 
      Mature megakaryocyte.
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Platelet Production
Platelets are small  (2 µm) non nucleated blood cells that play a 
vital  role  in  hemostasis  and  are  produced  in  the  bone  marrow  from 
megakaryocytes1.Megakaryocytes  are  descended  from  pleuripotent 
hematopoietic  progenitors  through  a  bipotential 
erythroid/megakaryocytic cell.After this stage megakaryoblasts undergo 
maturation to  megakaryocytes  stimulated by thrombopoietin  and other 
cytokines  and  chemokines.Maturation  is  dependent  on  transcription 
factors  GATA  1  and  GATA  2  together  with  cofactor  FOG1.This 
maturation is accompanied by endomitosis which is increasing cellular 
DNA content  without  proliferation.  During  a  terminal  phase  of 
megakaryocytic differentiation, platelets are produced from cytoplasmic 
projections  known  as  protoplatelets.Transverse  bands  of  microtubules 
form along longitudinal  bundles of microtubules in the proptoplatelets 
with  breakage  at  constriction  zones,and  liberation  of  newly  formed 
platelets  from the  tip  of  the  protoplatelet.Upon release  from the  bone 
marrow platelets circulate in a quiescent state but are activated rapidly 
upon blood vessel injury and play a crucial role in the primary hemostatic 
response.
Platelet Morphology
Bizzozero  (1882)  described  platelets  in  mesenteric  vessels  of 
rabbits  and  guinea  pigs.  He  demonstrated  their  adhesive  qualities, 
participation in thrombosis and role in coagulation of blood. Origin of the 
platelet from the megakaryocyte was established by the studies of Wright. 
The platelets in peripheral blood are heterogeneous with respect to size, 
density, staining characteristics.  Their morphology also varies with the 
methods by which they are examined ,the anticoagulant and  isolation 
method employed and the temperature. In wet preparations, platelets are 
colourless,  moderately  refractile  bodies  that  are  discoid  or 
elliptical.Under dark field illumination they are translucent and reveal a 
sharp contour. A few immobile granules are present in the centre of the 
cell. In polychrome stained smears platelets appear round, oval and rod 
shaped. Azurophilic granules are seen in a hyaline light blue cytoplasm. 
The terms granulomere and hyalomere have been applied to the granular 
and hyaline portions respectively.
Platelet dimensions and variations in disease
Average   dimensions  of  the  human  platelet  is  3.6  ±  0.7µm in 
diameter and 0.9±0.2 µm in thickness.
Platelet anisocytosis and macrocytosis have been studied in stained 
smears when platelet production is accelerated. Platelets that are 2.5 µm 
in  diameter  or  have  mean  platelet  volumes  in  excess  of  13  fl.
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(megathrombocytes)  constitute  less  than   10%  of  population.  These 
megathrombocytes  increase in  accelerated platelet  destruction eg.  auto 
immune thrombocytopenia.Platelets with giant fusion granules have been 
described in individuals with refractory anemia and preleukemia.Platelet 
sizing with automatic particle counters have revealed abnormally small 
platelets  in  association  with  aplastic  anaemia,  sepsis-associated 
thrombocytopenia  and  hypersplenism  .By  contrast  large  and  bizarre 
platelets are often noted after splenectomy in patients with myelofibrosis, 
haemorrhagic  polycythaemia  and polycythaemia  vera.Certain  forms  of 
thrombocytopenia  associated  with  disordered  platelet  function  are 
characterized  by  particularly  large  giant  platelets.  In  peripheral  blood 
smears platelets may adhere to   the periphery of the neutrophils called 
platelet satellitism. This is also seen as an invitro artifact resulting from 
Ig E or  Ig M  platelet agglutinins that are active in anticoagulated blood.
Megakaryocyte
These are precursors of platelets which are exceedingly large cells 
ranging from 35-160 µm in diameter.  They contain an irregular lobed, 
ring or doughnut shaped nucleus that is made up of dense chromatin that 
stains dark blue  with Wright’s stain. The cytoplasm is abundant light 
blue packed except for a narrow rim at the periphery with fine azurophilic 
granules.
Variations in size and morphology
When platelet production is accelerated, megakaryocytes increase 
both in size and number. In various forms of thrombocytopenia caused by 
accelerated platelet destruction, one may see immature forms that are not 
present in normal marrow, morphologically abnormal and degenerating 
megakaryocytes that do not appear to be producing platelets.
Abnormally large hyperlobulated megakaryocytes with thin nuclear 
chromatin have been described in folic acid and Vitamin B12 deficiency. 
Numerous morphologically abnormal megakaryocytes  often are noted in 
marrow specimens by biopsy from patients  with myelofibrosis.  Micro 
megakaryocytes are common in patients with pre leukemia and chronic 
myelomononcytic leukemia.
EM appearance of platelets
Electron Microscopy reveals a fuzzy coat (glycocalyx) extending 
14 to 20 nm from the platelet surface, which is thought to be composed of 
membrane glycoproteins,glycolipids,mucopolysaccharides and adsorbed 
plasma proteins 2 .
Platelets  move  in  an  electric  field  as  if  they  have  net  negative 
surface charge.  Sialic acid residues attached to proteins and lipids are 
major contributors to this negative charge3.Electrostatic repulsion created 
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by the negative surface charge may help prevent resting platelets from 
attaching to each other or to negatively charged endothelial cells.
The surface of the platelet has a number of indentations that are an 
elaborate  channel  system  composed  of  invaginations  of  the  plasma 
membrane that extend throughout the platelets.
The contents of the platelet granules can gain access to the outside 
when the granules fuse with either the plasma membrane or any other 
region of the open canalicular system. Similarly, glycoprotiens contained 
within granule membrane can join the plasma membrane after granule 
fusion with either the plasma membrane or the open canalicular system.
Platelet function
As stated earlier, platelets ordinarily circulate in the blood stream 
in a quiescent state but undergo explosive activation following damage to 
the  vessel  wall  leading  to  rapid  formation  of  a  platelet  aggregate  or 
vascular plug and occlusion at the site of damage. Platelets are therefore 
enriched with signalling proteins and surface receptors that enable them 
to achieve a rapid response.4, 5
The responses associated with platelet activation and their roles in 
haemostasis is discussed below.
Adhesion 
The initiating event following vascular damage is platelet adhesion 
to  exposed  subendothelial  matrix  proteins.  The  platelet  glycoprotein 
receptors which mediate adhesion are dependent on  rate of shear. Under 
the intermediate to high shear found in arterioles, this event is strictly 
dependent on Von-Willebrand factor VWF and its receptor GP 1b- IX – V 
complex.   Adhesion applies also to recruitment of circulating platelets 
into the thrombus. The platelet bound VWF that supports these events is 
derived from plasma and via secretion from platelet α-granules. Adhesion 
to the growing thrombus is supported by binding of  fibrinogen to the 
Integrin α IIbβ3 a process that is more correctly termed aggregation.
Shape change and spreading
Upon  activation  platelets  become  spherical  and  extend 
pseudopodia to enable them to attach to other platelets and to the vessel 
wall.  The transition  to  a  sphere increases the optical  density.  This  is 
mediated  by  phosphorylation  of  myosin  light  chains  by   elevation  of 
intracellular  Ca2+ ions  which  activate  myosin  light  chain  kinase  or 
through inhibition of myosin light chain phosphatase.
Adhesion  of  platelets  to  a  reactive  surface  such  as  collagen  or 
fibrinogen is  first characterized by transition from a discoid to a more 
rounded form but this is then followed by formation of filopodia which 
grow from the periphery of the cell and lamellipodia which fill in the area 
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between adjacent filopodia. As the platelet flattens and spreads, granules 
and organelles  are  squeezed  into the centre  of  the cell  resulting in  a 
characteristic fried egg appearance.Granules are secreted from the centre 
of the cell directly into the surface open canalicular system before release 
into the surrounding medium.These dramatic changes in morphology are 
brought  about  by  a  powerful  severing  and  reassembly  of  actin 
cytoskeleton through regulation of a number of actin regulatory proteins. 
Aggregation
This  involves  crosslinking  of  platelets  through  binding  of 
fibrinogen or other ligands such as VWF to Integrin  αIIbβ3 on adjacent 
cells. The major platelet Integrin GP IIb –IIIa forms a bridge between the 
platelet cytoskeleton and the polymerized fibrin that is generated by the 
coagulation cascade 6 .
Upon platelet activation,αIIbβ3 undergoes conformational change 
that increases the affinity for the fibrinogen,VWF, fibronectin and CD40 
ligand.  Binding  of  fibrinogen  to  αIIbβ3  reinforces  platelet  activation. 
Elevation of Ca2+  is required for rapid activation of αIIbβ3 and plays an 
essential role in thrombus formation.
Secretion
Platelets  contain three main types of  storage granules.  Dense,  α 
granules and lysosymes each of which rapidly release their contents upon 
activation.α granules are most numerous- about 80/Platelet and contain a 
rich  diversity  of  proteins  and  membrane  receptors  that  support  many 
processes in haemostasis.  Dense granules contain high levels  of  small 
molecules that support platelet activation and mediate vasoconstriction. 
Lysosymes  also  release  their  contents  on  activation.  Platelet  dense 
granules contain ADP and ATP, 5HT and Ca2+ ions. The rapid release of 
ADP  from  dense  granules  plays  a  major  positive  feedback  role  in 
promoting  platelet  activation.  Platelet  α  granules  contain  fibrinogen, 
VWF, Integrin αIIbβ3. P-Selectin in the α granule membrane stabilizes 
the thrombus. Factor V,VIII,protein- S,Chemokines like Platelet factor 4 
and RANTES, which attract circulating leukocytes, are also found in the 
α granules.
Recently  a  component  of  α  granules,  the  vitamin  K  dependent 
protein GAS 6 plays a major role on supporting platelet aggregation.
Phospholipase A2 and Thromboxane A2  are the two  major platelet 
positive feedback agonists. Platelet derived micro particles are generated 
during platelet activation and reinforces thrombus formation. Platelets are 
the force generating components of clot retraction.    
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Approach to a patient with Thrombocytopenia
Definition: Thrombocytopenia  is defined as a platelet count below 
the normal range of 150 – 400 x 10 9/L .
It  is  the most  common cause of abnormal bleeding.  Despite the 
number and diversity of disorders that may be associated aetiologically, 
thrombocytopenia  results  from  mainly  four  processes  –  artifactual 
thrombocytopenia,deficient  platelet  production,accelerated  platelet 
destruction and abnormal distribution or pooling of platelets within the 
body.
When  faced  with  an  asymptomatic  patient  with  a  low  platelet 
count,  the possibility of artifactual or pseudothrombocytopenia has to be 
excluded.  Artifactual  thrombocytopenia  or  falsely  low  platelet  counts 
occurs  exvivo  when  platelets  are  not  counted  accurately.  Inaccurate 
counting may occur  in  the presence of  giant  platelets  or  with platelet 
satellitism.7,8 The most common cause of artifactual thrombocytopenia is 
platelet  clumping.  This  is  caused  by  anticoagulant  dependent  platelet 
agglutinins that are immunoglobulins IgG,A,M. It is most common with 
EDTA anti coagulant 9 as evidenced by the studies of Gowland et al. The 
presence of platelet clumps on examination of the peripheral blood smear 
and  normal  platelet  count  using  citrated  blood  confirms  pseudo 
thrombocytopenia as the cause. Electronic cell counters sometimes show 
false  low counts  due to  giant  platelets.  If  repeated samples show low 
counts  which  do  not  correlate  with  the  clinical  parameters,  it  is 
mandatory to confirm platelet count by manual counting methods and to 
confirm the count by a well stained peripheral smear.
If thrombocytopenia is confirmed, a stepwise evaluation should be 
undertaken to assess the causes 10 .
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ALGORITHM FOR WORKUP OF THROMBOCYTOPENIA 
Clinical history in the evaluation of thrombocytopenia
A detailed clinical history is very helpful in arriving at a possible 
cause of thrombocytopenia and should include the following:
Bleeding            age at onset Congenital thrombocytopenia may 
present as a delayed onset 
Acquired eg CMV infection may 
present at birth. 
 
 
Thrombocytopenia (Platelet count <150 x 109 / L)
Examine peripheral blood smear
Look for specific diagnostic cluesNon diagnostic
Schistoctyes
Heriditary TCP 
Giant 
Platelets 
Artifactual 
Thrombocytopenia
Platelet clumpsSuspicious of prim ry marrow 
disorder 
SpherocytesIsolated thrombocytopenia
Confirm hemolysis  
(LDH, bilirubin)Yes No * Nucleated RBC
* Bilobed neutrophil 
* Macrocytes
* Blasts
* Unexplained 
Direct Coombs Recent 
No
DIC panel 
Positive Negative Yes
Bone Marrow 
Chemotherapy 
induced 
Evan’s 
syndrome
Primary marrow disorders 
* MDS 
* Lymphoma 
* Myeloma 
* Leukaemia 
* Aplastic anaemia 
ITP 
Drug induced 
DICTTP/HUS
Positive Negative 
 Acute
Chronic
Spontaneous 
Trauma / surgical intervention 
Note: In females, a 
detailed menstrual and obstetric history must be obtained.
Predominantly mucocutaneous 
Deep seated / intramuscular 
Associated symptoms 
* Fever 
* Drugs 
* Arthralgia / arthritis 
* Jaundice
* Pallor 
Transfusions 
given  
Platelet alone 
other components as well 
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Physical Examination
This  must  include  evaluation  of  pallor,  fever,  lymphadenopathy, 
jaundice,  sternal  tenderness,  gum  hyperplasia,  hepatomegaly, 
splenomegaly,  ascites  and  exanthematous  rash  for  viral/vasculitic 
aetiology.
Laboratory investigations
The  results  of  the  complete  blood  count  and  review  of  the 
peripheral blood smear are critical components in the initial evaluation of 
the thrombocytopenic patient.11
Platelet count
Since the introduction of  automated cell  counters,the number  of 
platelet counts performed manually have decreased significantly.12,5  The 
accepted normal range of the platelet count is 150-400x109/L.
Mean platelet volume [MPV]
This is obtained using new generation cell counters.  The normal 
values of MPV depends on the platelet count. To determine if the platelet 
values are normal the platelet count and the MPV should be related to a 
normogram with a combination of high, low and normal platelet count 
and a high, low and normal MPV.A high MPV has been correlated with 
myeloproliferative  disorders  and  thalassemia  and  a  low  MPV  is 
associated  with  hypoplasia  and  cytotoxic  drugs.  For  patients  with 
thrombocytopenia,  a high MPV indicates increased platelet  destruction 
and a  low MPV suggests  decreased platelet  production.  Normal  MPV 
ranges are approximately 7-11 fl.
PLATELET DISTRIBUTION WIDTH[PDW]
PDW is a measure of the dispersion of the platelet sizes.In patients 
with rapid turnover,the platelets will in general be larger due to the larger 
size of the newly produced platelets and their PDW will be increased due 
to  mixture  of  large  and  small  platelets.  True  congenital 
macrothrombocytopenias usually  have uniformly large platelets  with a 
very high MPV and normal PDW.
BONE MARROW EXAMINATION
Bone marrow examination and trephine biopsy can be performed to 
evaluate  etiology  of  thrombocytopenia.In  a  thrombocytopenic  patient, 
when no other reason for low platelet counts can be determined, the bone 
marrow  examination  is  useful  for  determining  the  presence  of 
megakaryocytes.  Absence  indicates  dysfunctional  marrow  while 
increased numbers  suggest  peripheral  destruction with  attempted bone 
marrow  decompensation.  Bone  marrow  examination  can  also  detect 
myelophthisic disorders such as acute leukemia or metastatic malignancy.
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COAGULATION PROFILE
Prothrombin  time,  activated  partial  thromboplastin  time,  plasma 
fibrinogen levels and D-dimer evaluation is done to exclude an associated 
coagulopathy.
Other  ancillary  investigations  relevant  in  the  work  up  of 
thrombocytopenia include Coomb’s test, serum LDH levels, serum uric 
acid levels, renal function tests, liver function tests and confirmatory tests 
pertaining to specific cases.
PATHOPHYSIOLOGICAL CLASSIFICATION OF 
THROMBOCYTOPENIA
I.DECREASED PRODUCTION:
MARROW INFILTRATIVE DISORDERS:
 Malignant disorders – haematological
• Lymphoma
• Leukemia
• myeloma
 Metastatic                                         
            Non neoplastic      Secondary              auto immune 
                                myelofibrosis granulomatous 
storage disorder 
  Infections– Lymphohistiocytic infiltration in 
                     CMV
INEFFECTIVE HAEMATOPOESIS
• Myelodysplastic syndromes
• Deficiency anaemias-B12 deficiency
HYPOPLASTIC DISORDERS 
Congenital
Aplastic anaemia 
Acquired * Idiopathic
                                                                            *  Drugs
    *  Chemicals
     *  Radiation
    *  Infection
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       4)  HERIDITARY THROMBOCYTOPENIAS
II. INCREASED  DESTRUCTION
1. Immune:             Isolated presentation
 Immune thrombocytopenia purpura             
                                                                                     As a part of 
Connective tissue 
disease
 Heparin induced thrombocytopenia
 Drug induced antibodies
 HIV
 Post transfusion
 Connective tissue diseases
2. Non Immune:
 DIC
 Sepsis
 Cardiac valves
 TTP/HUS
 Kasabach Merrit Syndrome
 HIV
 Post transfusion purpura
III. SEQUESTRATION:
 Hypersplenism
 Macrophage activation syndromes
DECREASED PRODUCTION DUE TO MARROW 
INFILTRATION
Thrombocytopenia  in  hematological  malignancies  are  clonal 
malignant  proliferations  of  the  hematopoietic  stem  cell  that  is 
characterized by the accumulation of blasts principally in the marrow at 
the  cost  of  impaired  production  of  normal  blood  cells  .13,14 Non 
hematological  malignancies  commonly  implicated  are  carcinomas  of 
lung,  breast  and  prostate.  Marrow trephine  biopsy  is  preferred  in  the 
detection of these tumours.
Non  neoplastic  conditions  causing  secondary  myelofibrosis  and 
consequent  cytopenias  including  thrombocytopenia  are  autoimmune 
disorders namely SLE, Rheumatoid arthritis and Sjogrens syndrome  15, 
granulomatous  disorders  of  marrow  including  viral,  fungal,  bacterial, 
rickettsial and toxoplasmosis16 and storage disorders including Gaucher’s 
disease and Niemann Pick disease.
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Common viral infections include HIV infection ,17 most common 
cause  in  North  America  and  cytomegalovirus  infection  causing 
lymphohistiocytic infiltration of the marrow.
INEFFECTIVE HAEMATOPOIESIS
Marrow  hypoplasia  due  to  ineffective  haematopoesis  include 
myelodysplastic  syndromes  and  deficiency  anaemias  notably  B12. 
Myelodysplastic syndromes are clonal stem cell disorders characterized 
by blood cytopenias  in  combination  with  a  hypercellular  marrow that 
often  exhibits  dysplastic  changes  in  any  of  the  three  haematopoietic 
lineages.  18 Thrombocytopenia  is  present  in  approximately  50%  of 
patients and occurs in conjunction with other cytopenias.19
In  megaloblastic  anaemia  due  to  Vit  B12  deficiency,  there  is  a 
moderate  reduction  of  platelet  count  rarely  <  40  X  109  /  L. 
Thrombocytopenia is due to ineffective megakaryopoiesis.
HYPOPLASTIC ANAEMIA
Hypoplastic disorders  affecting marrow include aplastic  anaemia 
which  is  a  clinical  syndrome  that  results  from marked  dimunition  of 
marrow  blood  cell  production.  The  decreased  production  results  in 
reticulocytopenia,  anaemia,  granulocytopenia,  monocytopenia  and 
thrombocytopenia.  In  paroxysmal  nocturnal  hemoglobinuria, 
thrombocytopenia can be accompanied by thrombotic manifestations due 
to activation of platelet by complement.
HERIDITARY THROMBOCYTOPENIA
These disorders are common in children and are due to congenital 
defects in platelet production. Bernard Soulier syndrome is a congenital 
deficiency of platelet GP 1b α / 1bβ/ 1X / V receptor.
THROMBOCYTOPENIA DUE TO PERIPHERAL DESTRUCTION 
OF PLATELETS
Immune Thrombocytopenia 
Immune  thrombocytopenia  is  a  relatively  common  disease  in 
adults. A Danish study noted incidence rate of 2.68 per 10000020. ITP is 
an autoimmune condition caused by antiplatelet antibodies which result 
in decreased platelet survival. The antibodies are frequently IgG in nature 
and directed against platelet antigens - GP II b / III a and GP 1b / 1X 
complexes. The spleen is the major site of platelet destruction. Frequently 
patients  are  young  adult  females.  Severe  thrombocytopenia  typically 
presents without anaemia or leukopenia.
Heparin induced thrombocytopenia
Heparin induced thrombocytopenia ( HIT) is a common cause of 
drug induced thrombocytopenia in  hospitalized  patients.  Two types  of 
HIT have been described.
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Type I HIT is a modest transient decrease is platelet count that 
occurs  within the  first  2-3 days after  heparin initiation and returns to 
normal spontaneously even with continuation of heparin.
Type  II  HIT is  seen  in  0.3  –  5  %  of  patients  treated  with 
unfractioned heparin 21. It is caused by antibodies against platelet factor 4 
– heparin complex. Thrombocytopenia sets is usually 2 weeks or more 
after  first  exposure.  Subsequent  exposure  results  in  thrombocytopenia 
immediately or after few days.
Post transfusion purpura
Post transfusion purpura is a rare complication of blood transfusion 
seen mostly in women. It presents as severe thrombocytopenia 5 – 10days 
after red cells or platelet transfusion. This is an alloimmune complication 
that occurs in patients who have developed antiplatelet antibodies from 
prior transfusion or pregnancy 27.
NON IMMUNE CAUSES OF PLATELET DESTRUCTION
Disseminated intravascular coagulation ( D1C)
DIC  is  a  systemic  process  caused  by  pathologic  thrombin 
generation characterized clinically by thrombosis and bleeding.
Etiological  factors  include  amniotic  fluid  embolism,  abruptio 
placentae, trauma, snake bite, leukemias (AML-M3) and adenocarcinoma. 
Thrombocytopenia  is  almost  universal  in  patients  with  DIC  due  to 
activation of the clotting mechanism 22.
Prosthetic cardiac valves
RBCs on contact with prosthetic valves are constantly subject to 
damage.  The  degree  of  anaemia  is  proportional  to  the  compensatory 
mechanisms. A good reticulocyte response ensures adequate haemoglobin 
values, nevertheless fragmented RBC can be a chronic trigger for a sub-
clinical microangiopathy resulting in chronic consumption of platelets.
Thrombotic thrombocytopenic purpura / Haemolytic uremic 
syndrome  (TTP/HUS )
TTP /  HUS is  a  relatively  uncommon life  threatening  cause  of 
thrombocytopenia23. Classic diagnostic pentad of TTP includes.
     1. Microangropathic hemolytic anaemia
     2. Thrombocytopenia
     3. Renal insufficiency
     4. Fever
     5. Mental status changes
The presence of thrombocytopenia and schistocytes > 1 / HPF on 
smear is commonly seen. Serum LDH is increased. Thrombocytopenia 
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can be severe with a median platelet count of 20000. A diagnosis of TTP 
–  HUS should  be  considered  is  a  patient  with  thrombocytopenia  and 
evidence of microangiopathy 24.
Kasabach Merrit Syndrome
It is a rare cause of destructive thrombocytopenia with cavernous 
haemangimas associated with microangiopathy, haemolytic anaemia.
SEQUESTRATION
1)  Hypersplenism
Splenomegaly  from  any  cause  including  neoplastic,congestive, 
infiltrative  and  infections  result  in  sequestration  of  blood  elements 
leading  to  cytopenias.  The  cardinal  features  of  hypersplenism  are  
a)  splenomegaly  b)  reduced  levels  of  one  or  more  blood  elements  in 
circulation  associated  with  increased  precursors.  c)  Correction  of 
cytopenia afte splenectomy 28.
Splenomegaly is almost always secondary to other disorders most 
commonly  cirrhosis  with  portal  hypertension.  Thrombocytopenia  is 
usually  of  moderate  severity  rarely  below  40000  /  µl.  Platelet 
transfusions are not effective as transfused platelets are also sequestered 
in the spleen.
2) Macrophage activation syndromes 
Systemic macrophage activation syndrome can occur in response 
to  a  number  of  different  stimuli.  Viral  infections  are  best  known,  but 
bacterial infections,  rheumatological disorders, intravenous alimentation 
and multiple organ failure are among other causes. This appears to be due 
to  lymphocyte  /  NK cell  driven macrophage stimulation  that  leads  to 
disseminated overactivity of the macrophages throughout the body25. An 
increase  in  the  number  and  size  of  endogenous  macrophages  with  or 
without haemophagocytosis, is a feature of this condition, best seen in the 
marrow,  but  also  in  the  spleen,  liver  and  lymphnodes.  There  may  be 
severe  functional  effects  of  the  cytokine  storm  with  bone  marrow 
depression,  hepatomegaly  and  increased  heptocellular  enzymes  and 
effects on the clotting cascade26. The condition abates when the inciting 
condition is treated or disappears or may at times be fatal.
Pregnancy and thrombocytopenia
Thrombocytopenia in pregnancy can occur in the following settings :
a) Gestational ( Incidental )
b) Immune thrombocytopenic purpura.
c) HELLP syndrome ( hemolysis, elevated liver enzymes and low 
platelets )
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d) Antiphospholipid syndrome and SLE.
e) Hypertensive disorders.
Most  common  is  incidental  thrombocytopenia   (upto  75%  of 
cases). Hypertensive disorders account for 20% of pregnancy associated 
thrombocytopenia  29.  Subset  of  these  patients  have  a  syndrome called 
HELLP30.
 
MATERIALS AND METHODS
This prospective study was conducted in the Goschen Institute of 
Pathology, Madras Medical College from 2007-2009. The study included 
33  subjects  who  presented   to  the  clinical  pathology  department  and 
medical OP departments of Madras Medical College.
Inclusion Criteria
Patients  presenting  to  the  clinical  pathology  and  medical  OP 
departments  who were  found  to  have  thrombocytopenia,  defined  as  a 
platelet  count  less  than  150  x  109 /  L in  an  automated  counter  and 
confirmed by peripheral smear examination.
Exclusion Criteria
Patients who,  after detailed clinical assessment and laboratory 
tests were diagnosed to have an immunological basis for 
thrombocytopenia.
A detailed history was elicited from each patient included in the 
study population.
1)  Patient identity details
These include name, age, sex, hospital number, address and unit.
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2)  Chief presenting complaints  and duration.
3) History  of  present  illness  -  The  relevant  symptomatology 
associated with the chief complaint.
4) Past history:
a) H/O chemotherapy / radiotherapy 
b) malignancies
c) previous surgery or blood transfusion
d) drugs  ingested  in  the  past  with  emphasis  on  intake  of  
indigenous medicines 
e) previous bleeding tendencies and site of bleeding 
f) chronic  ailments  like  diabetes  mellitus,  systemic 
hypertension,  bronchial  asthma,  ischaemic  heart  discase, 
pulmonary tuberculosis, epilepsy.
5) Personal history
a) alcohol intake-quantity, duration
b) Tobacco / paan intake and duration
c) Extra marital sexual contact
d) Menstrual history ( in women) : age at menarche, duration of 
the menstrual flow, regularity and duration of the menstrual 
cycle, age at menopause.
e) Obstetric  history  (in  women):  marital  status,  number  of 
children, abortions.
General examination
This included assessment of vital parameters ,  nutritional status, 
pallor,  icterus,  clubbing,  pedal  oedema,  evidence  of  bleeding,  sternal 
tenderness, lymphadenopathy.
Other  features  were  assessed  if  warranted  on  the  basis  of 
provisional diagnosis. 
Systemic examination 
Assessment  included  examination  of  cardiovascular,  respiratory, 
central nervous system and abdomen.
A  provisional  clinical  diagnosis  was  made  with  differential 
diagnosis and necessary laboratory tests were performed which included 
the mandatory tests as per the protocol besides other  relevant specific 
tests.
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Laboratory tests 
Peripheral  venous blood obtained from antecubital venipuncture 
was  used.  Appropriate  amounts  of  blood  were  transferred  into 
tripotassium EDTA vacutainer for complete blood count, sodium citrate 
3.2  %  for  coagulation  profile  and  plain  blood  in  sterile  tubes  for 
biochemical analysis. Some blood was preserved at -20oC.
The complete blood count was performed using SYSMEX KX-21 
3  part  cell  counter.  The  following  parameters  were  included:  Total 
leucocyte  count,  differential  count,  haemoglobin,  hematocrit,  MCV, 
MCH, MCHC, red cell distribution width, platelet count, mean platelet 
volume  and  platelet  distribution  width.  ESR  was  measured  by 
Westergren’s method. Peripheral blood smear stained by Leishman stain 
was examined.
Bone marow study
Bone marrow aspirate was obtained from posterior superior iliac 
crest using 16G bone marrow aspirate needle. Smears were stained with 
Leishman stain. Bone marrow iron studies were performed in some cases. 
In relevant cases bone marrow trephine biopsy was performed and H & E 
stained paraffin sections were examined.
Coagulation profile
Blood with appropriate amount of 3.2 % sodium citrate was used 
for  prothrombin  time,  activated  partial  thromboplastin  time  and 
fibrinogen  estimation.  PT,  aPTT  and  fibrinogen  was  done  using 
coagulatory method in SYSMEX CA-500. D-dimer levels were estimated 
in select cases.
Biochemical tests
Plain blood was used for assessing liver function, renal function 
and estimation of serum lactate dehydrogenase.
Liver function tests 
The following parameters were assessed
a) Total and direct bilirubin
b) SGOT, SGPT
c) Serum alkaline phosphatase 
d) Total protein and albumin
Renal function tests
The following parameters were assessed
a) Urea
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b) Creatinine 
c) Serum electrolytes
Serum LDH was estimated in all patients. 
Ultrasonogram was performed in all cases.
For patients with suspected infections, the following tests were done: 
a) Smears for MP, MF and QBC method
b) MSAT for Leptospirosis
c) Dengue IgG and IgM antibodies
d) HIV- I & II antibodies by rapid and ELISA method
e) Blood culture for enteric and non enteric organisms
f) Gram stains
g) Stains for AFB, fungus
h) Sputum examination 
i) Rheumatoid factor
j) ANA
k) ACLA
When malignancy was suspected,  the following tests were performed. 
a) CT scan
b) MRI
c) Fluid analysis for effusions including cytological study.
d) FNAC in cases of palpaple masses. eg. cervical 
lymphadenopathy.
e) Histopathology to exclude or confirm malignancies.
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RESULTS
The total number of cases were analysed and categorized according 
to the final diagnosis. The distribution was as follows. (Table 1).
1. DECREASED PRODUCTION
(i)    Haematological malignancies
a.  Acute myeloid leukemia                           6
b. Acute lymphoblastic leukemia                  3
c. Chronic myeloid leukemia in transformation 1
d. Chronic myeloid leukemia with myelofibrosis  1
(ii)  Hypoplastic disorders
(i). Aplastic anaemia                                                  4
2. INEFFECTIVE HAEMATOPOIESIS
(i) Megaloblastic anaemia                                           1
(ii) Myelodysplastic syndrome                                     2
3. CONGESTIVE SPLENOMEGALY
WITH HYPERSPLENISM                                    1
4.  INFECTIONS
(i) Viral                                                     3
(ii) Malarial                                                2
(iii) Leptospirosis                                         1
(iv) HIV with aspergillosis                1
5. CONNECTIVE TISSUE DISEASE
(i) SLE with pancytopenia                  1
(ii) Juvenile Rheumatoid arthritis 
          with pancytopenia                             1
(iii)    SLE with antiphospholipid antibody syndrome 
and pancytopenia     1
(iv) Ankylosing spondylitis   1
6. DRUG INDUCED THROMBOCYTOPENIA            2
7. DISSEMINATED INTRAVASCULAR 
COAGULATION     1
8. MICROANGIOPATHIC HAEMOLYTIC ANAEMIA   1
These  cases  were  then  analysed  with  the  entire  clinical  and 
laboratory profiles and the possible pathogenesis outlined.
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Table1.Distribution of Cases
S.No Category No. of Cases
1. Decreased Production 15
2. Ineffective haematopoeisis 3
3. Hypersplenism with congestive splenomegaly 1
4. Infections 7
5. Connective Tissue Disease 4
6. Drug Induced 2
7. Disseminated Intravascular Coagulation 1
8. Microangiopathic haemolytic anaemia 1
DISCUSSION
HAEMATOLOGICAL MALIGNANCIES
Thrombocytopenia  is  well  known  in  acute  haematological 
malignancies  due  to  extensive  infiltration  of  the  marrow  by  blasts 
replacing  normal  haematopoietic  elements.31.Our  study  also  showed  a 
significant reduction in megakaryocytes in the marrow in all the cases of 
acute leukaemia. Our study included 6 cases of  AML,3 cases of ALL 
(Figs 1,2,3,4)
One  case  of  AML  M5  in  addition  showed  dysplastic 
megakaryocytes in the marrow and a significant prolongation of PT and 
APTT.
The  dysplasia  producing  an  ineffective  megakaryopoiesis  and 
increased  coagulation  parameters  with  gastrointestinal  bleeding 
suggestive  of  an  underlying  disseminated   intra  vascular  coagulation 
could be additional contributory factors to the thrombocytopenia.
Further this patient was on the 4th cycle of chemotherapy with a 
possible drug induced myelosuppression.
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Another  case  of  AML  presented  as  pancytopenia  with 
prolonged  APTT.  The  possibility  of  myelodysplastic  syndrome 
converting to AML was considered.32 The patient had a history of native 
medicine intake the same probably contributing to the myelodysplasia 
and hypoplastic kidney probably chronic pyelonephritis.
One  case  of  ALL had  a  significant  elevation  of  LDH  with  a 
prolongation  of  PT and  APTT.  He  was  partially  treated  outside.  The 
possibility of tumour lysis syndrome with DIC was considered.
One  patient  presented  with  pancytopenia.33 with  bone  marrow 
showing  lymphoblasts  and  FNAC  of  cervical  node  suggesting  a 
lymphoproliferative disorder.
Two cases of CML presented with thrombocytopenia.
One  patient  had  epistaxis,  arthralgia  and  fever,  a 
leucoerythroblastic  blood  picture,  18%  myeloblasts,  bone  marrow 
showing 42% myeloblasts, dysplasia and occasional hemo phagocytosis. 
Increased reticulo endothelial cells,prolonged  PT, reduced fibrinogen and 
increased LDH were also observed.
Apart  from the conversion of  CML to AML accounting for  the 
thrombocytopenia, the other possibilities considered were: 
1. myelodysplastic syndrome with ineffective megakaryopoiesis
2. haemophagocytic histiocytosis as evidenced by increased reticulo 
endothelial cells and haemophagocytosis in the marrow, increased 
prothrombin time, decreased fibrinogen and increased LDH.
The second case of CML presented with pancytopenia. She was on 
treatment with Hydroxyurea and Busulphan based on the availability. The 
bone  marrow  aspiration  and  biopsy  were  repeated  in  view  of  the 
persistent  thrombocytopenia.Marrow showed  extensive  fibrosis  with  a 
few  clusters  of  megakaryocytes.  The  following  possibilities  were 
considered.
a. drug induced fibrosis
b. evolving megakaryoblastic leukemia
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HYPOPLASTIC DISORDERS
We had 4 cases of aplastic anaemia in our study. One patient had an 
absent  left  kidney  and  a  scaly  skin  with  mild  dystrophy  of  toe  nails 
suggestive of possible dyskeratosis congenita.
INEFFECTIVE HAEMATOPOIESIS
Although a common disorder, our study included only one case of 
megaloblastic anaemia in a young female who responded well to B12 and 
folate,  ineffective  megakaryopoiesis  being  the  main  contributor  to 
thrombocytopenia.
There were two cases of primary MDS in this study, both patients 
being  symptomatic  for  the  pancytopenia  including  thrombocytopenia. 
Marrow  showed  trilineal  dysplasia,  ineffective  haematopoiesis 
contributing to thrombocytopenia.In addition dysplasia  was noted in 2 
denovo acute leukaemia and CML in blast crisis. Dysplasia (secondary) 
was  also  noted  in  two  cases  of  connective  tissue  disorder,one  drug 
induced thrombocytopenia and a patient with HIV.
Our  study  had  only  one  case  of  hypersplenism  with  splenic 
sequestration  ie  a  case  of  decompensated  liver  disease  with  portal 
hypertension and congestive  splenomegaly.  Hepatotropic  viral  markers 
were  negative.and  patient  also  had  GradeIII  oesophageal  varices, 
decreased fibrinogen ie 112 mg/dL and ascites.Hepatic coagulopathy was 
considered as an additional factor to thrombocytopenia.
INFECTIONS
Four  cases  of  acute  febrile  illness  with  thrombocytopenia  were 
included in the study. 2 were positive for Dengue IgG, IgM.Peripheral 
destruction  of  platelets  with  cross  reacting  antibodies  is  the  common 
pathogenetic  mechanism  for  thrombocytopenia33.  One  patient  had  in 
addition  an  increased  LDH with  marrow showing  haemophagocytosis 
with a possibility of sequestration of platelets in the macrophages as an 
additional contribution to thrombocytopenia. One patient had decreased 
megakaryocytes  in  the  marrow  and  reactive  lymphocytes  in  smear 
(Fig.5).The third case of acute febrile illness presented with a prolonged 
pancytopenia with the marrow appearing cellular with partial maturation 
arrest  in  granulocytic  series,  a  few  megakaryocytic  bare  nuclei  and 
haemophagocytosis.  With  the  APTT prolongation,  clinical  features  of 
bleeding  and  evidence  of  haemophagocytosis  the  possibility  of  virus 
associated macrophage activation was considered25,26.
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The fourth case also presented with an acute febrile illness and was 
MSAT  positive  for  Leptospirosis.  In  addition  to  immune  mediated 
platelet destruction, inhibited platelet production was considered in the 
pathogenesis of thrombocytopenia.
Two cases  of  malaria  P.vivax infestation.  (Fig.6)  presented  with 
thrombocytopenia,the pathogenesis of thrombocytopenia being probably 
due to 34,16 :
a) splenic sequestration and enhanced macrophage activity.
b) activation  of  platelets  by  haemolysed  red  cells  resulting  in 
DIC.APTT was prolonged in one patient
c) Quinine and sometimes chloroquine are sometimes known to cause 
thrombocytopenia.
There was no evidence of renal dysfunction in both these cases.
We had one patient with HIV presenting with thrombocytopenia. 
Marrow appeared hypocellular with dysplastic changes. The patient also 
had  Aspergillus  pneumonia  (Fig.7,8).The  following  contributors  to 
thrombocytopenia were considered:
1) HIV induced marrow changes
2) Drug induced myelopathy
3) Myelodysplasia with ineffective megakaryopoiesis
There was no evidence of sepsis or DIC in this patient
CONNECTIVE TISSUE DISEASE
4 cases of  connective tissue disease were included in this study 
because  of  possible  non  immune  mechanisms  contributing  to 
thrombocytopenia.
1. One case of SLE presenting with pancytopenia, bleeding diathesis, 
prolonged  APTT,  low  fibrinogen,  increased  LDH,  the  marrow 
showing  adequate  haematopoietic  elements,  increased 
reticuloendothelial  cells  with  haemophagocytosis.  She  had 
evidence  of  E.coli  infection  at  the  time  of  admission.  The 
possibility  of  macrophage  activation  syndrome  was  considered 
with a good response to appropriate antibiotics and plasmapheresis
2. A case of Juvenile rheumatoid arthritis also presented with features 
of macrophage activation syndrome with severe pancytopenia and 
hepatic  dysfunction  as  evidenced  by  grossly  increased  serum 
alkaline phosphatase and coagulation parameters,  low fibrinogen 
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and increased LDH, clinical hepatospenomegaly and generalized 
lymphadenopathy.
3) We  had  a  third  interesting  case  of  a  46/F  who  presented  with 
thrombocytopenia and thrombosis.ANA and ACLA were positive. 
Hams test was negative.  She was on steroids and Acitrom. In 6 
months, she presented with an abdominal wall hematoma with a 
grossly  prolonged  APTT  and  persistent  thrombocytopenia.  The 
peripheral  blood showed circulating  normoblasts  and occasional 
red cell fragments. The increased APTT with a fairly normal PT 
and  deep  seated  intramuscular  bleeding  suggested  possibility  of 
acquired antibodies to coagulation factors. The thrombocytopenia, 
apart  from  the  immune  mediated  platelet  destruction,  could  be 
aggravated due to dysplasia in megakaryocyte series
4) One case of ankylosing spondylitis, a young male presented with 
anaemia  and  thrombocytopenia  with  a  prolonged  APTT.  He 
presented  with  mild  splenomegaly  and  was  on  NSAID  for 
spondyloarthropathy.Marrow  appeared  hypercellular  with 
increased  megakaryocytes  with  micromegakaryocytes,  moderate 
myeloid hyperplasia,increased reticuloendothelial cell activity.The 
following possibilities were considered:
1) Increased  disease  activity  as  evidenced  by  increased 
reticuloendothelial cells,increased ESR, prolonged APTT and low 
normal fibrinogen and macrophage engulfment of platelets.
2) NSAID  induced  peripheral  destruction  due  to  cross  reacting 
antibodies and myelopathy resulting in dysplasia/suppressions.
Drug induced Thrombocytopenia:
1) NSAID induced thrombocytopenia included one case of ankylosing 
spondylitis (Vide supra).
2) A case of tuberculosis on class I Anti tuberculous therapy for 2 
months which included Rifampicin developed thrombocytopenia. 
Marrow   evaluation  showed  decreased  megakaryocytes  and  no 
granuloma  or  fibrosis.  The  patient  was  subsequently  put  on  a 
regime  without  Rifampicin  and  platelet  counts  gradually  
recovered 35,36,37.
DISSEMINATED INTRAVASCULAR COAGULATION:
A 52 year old male on treatment for non small cell lung carcinoma 
with a positive cytology in pleural and ascitic fluid and endobronchial 
biopsy  (Fig.  9)  developed  a  bleeding diathesis  while  on  therapy.  The 
complete  blood  count  showed  pancytopenia,  increased  coagulation 
parameters low normal fibrinogen, increased fibrin degradation products 
and D-dimer, increased LDH. The marrow aspirate was hypocellular and 
565656
the  trephine  biopsy  showed  necrotizing  granulomatous  inflammation 
negative for AFB (The patient was however on ATT before the diagnosis 
of malignancy).The cause of thrombocytopenia in this patient could be 
attributed to  
1. Marrow  infiltration  by  necrotizing  granulomata  
? Tuberculosis?Carcinomatosis.
2. Increased  coagulation  parameters  and  LDH  with  a  d-dimer  
increase – Disseminated carcinoma with a chronic consumption.
RED CELL FRAGMENTATION:
A 28 year old male with a prosthetic cardiac valve for Rheumatic 
heart disease for over 20 years presented with fever, breathlessness and 
bleeding gums. Labroatory data showed a severe thrombocytopenia, low 
normal  fibrinogen  and  increased  LDH.  The  marrow  showed  myeloid 
hyperplasia  with  adequate  megakaryocytes  with  peripheral  smear 
showing  mild  anisocytosis  with  occasional  fragmented  RBC.USG 
showed minimal splenomegaly.
 
The possibility of :
1. Chronic red cell fragmentation with underlying subclinical platelet 
consumption compounded by
2. A subsequent infection (infective endocarditis) resulting in severe 
thrombocytopenia and clinical bleeding.
The  analysis  of  33  cases  of  thrombocytopenia  revealed  an 
interesting mix of etiopathogenetic factors. With the limited laboratory 
facilities it was possible to deduce to a reasonable level the pathogenetic 
mechanisms  which  in  many  cases  were  confirmed  by  response  to 
treatment on follow up of patients.
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SUMMARY AND CONLUSION
Thrombocytopenia  with  or  without  bleeding  manifestations  is  a 
common problem in general clinical practice. To treat or not to treat and 
how to treat would depend a lot on etiopathogenesis, of this problem. As 
pathologists,  it  is  for  us  to  highlight  this  point  in  order  to  help  the 
clinician manage the patient in a scientific and beneficial manner. As we 
have  seen,  supportive  parameters  like  a  good  peripheral  smear 
examination, coagulation profile, comprehensive marrow evaluation and 
certain biochemical parameters with the clinical profile go a long way in 
narrowing the etiology and maximizing treatment benefits. It should be 
remembered that  all  thrombocytopenias are  not  immune mediated and 
therefore a  presumption to  this  effect  should not  be made in  the first 
instance.  Also  in  cases  of  confirmed  immune  thrombocytopenia  one 
should have an open mind about other non immune processes creeping 
into pathogenesis during progression of disease. This is a limited study 
and evaluation of larger number of patients is therefore necessary for a 
more comprehensive and comparative analysis. 
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KEY TO MASTER CHART 
1. TLC - Total Leucocyte count 
2. DC - Differential count 
3. RBC count - Red blood cell count 
4. Hb - Haemoglobin 
5. HCT - Haematocrit 
6. MCV - Mean corpuscular volume 
7. MCH - Mean corpuscular Haemoglobin 
8. MCHC - Mean corpuscular Haemoglobin concentration 
9. RDW - Red cell distribution width 
10. ESR - Erythrocyte sedimentation rate 
11. Plt count - Platelet count 
12. MPV - Mean platelet volume 
13. PDW - Platelet distribution width 
14. BT - Bleeding time 
15. PT - Prothrombin time 
16. APTT - Activated partial thromboplastin time 
17. LDH - Lactate dehydrogenase 
18. LFT - Liver function tests 
19. RFT - Renal function tests 
20. USG - Ultrasonogram 
21. PS - Peripheral smear 
22. BM - Bone marrow 
23. N - Normal 
24. MK - Megakaryocyte 
25 MB - Myeloblast  
26. Hyper - Hypercellular 
27. EP dysp - erythroid precursors dysplastic 
28. Mo - Monoblasts 
29. HM - Hepatomegaly 
30. AML - acute myeloid leukaemia 
31. SM - splenomegaly 
32. HSM - hepatosplenomegaly 
33. TB - Total bilirubin 
34. AP - alkaline phosphatase
35. dysplMK - dysplastic Megakaryocyte 
36. PCP  - Pancytopenia 
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37. fibr - fibrinogen
38. LB - lymphoblast 
39. PE - pleural effusion
40. LPD - lympho proliferative disorder
41. U - Urea 
42. Cr - Creatinine 
43. TCP - thrombocytopenia 
44. RE - Reticuloendothelial  
45. MDS - myelodysplastic syndrome 
46. NB - Normoblast 
47. ANA - antinuclear antibodies 
48. ACLA - anticardiolipin  antibody 
49. SLE - systemic lupus erythematosis 
50. HP   –  haemophagocytosis 
51. EH   - erythroid hyperplasia 
52. DCT - Direct Coomb’s test 
53. RL  – reactive lymphocyte
54. P – polymorph 
55. CRP -  C-reactive protein 
56. RA - Rheumatoid arthritis 
57. DCLD  - Decompensated  chronic liver disease 
58. dil PV, SV – dilated portal vein,  splenic  vein 
59. NSCLC  - Non small cell lung carcinoma 
60. FDP - fibrin degradation products 
61. DIVC – Disseminated intravascular coagulation 
62. Hypo – Hypocellular marrow 
63. Ap. An  - Aplastic anemia 
64. LKA – Left kidney absent 
65. LKH - Left kidney hypoplastic 
66. FNA - Fine needle aspiration 
67. RC - Renal cysts
68. LEB - Leucoerythroblastic picture
69. CML B.C. - Chronic myeloid leukaemia blast crisis 
70. LP - Lymphocyte preponderance 
71. FC liver - Fatty change liver
72. Ret hge - Retinal haemorrage
73. Hy MDS - hypoplastic MDS
74. Par wall hem - Parietal wall hematoma 
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75. mic MK - micro megakaryocyte
76. gi plt - giant platelet 
77. MKA - megakaryocyte adequate 
78. UC - Urine culture 
79. E.C. - E.coli 
80. Meg Ane - Megaloblastic anaemia
81. MH - myeloid hyperplasia 
82. Mil TB - military tuberculosis 
83. Rif Ind. TCP - Rifampicin induced thrombocytopenia 
84. Asc - Ascitis 
85. Den IgG, IgM - Dengue IgG, IgM
86. LCP - Leucopenia 
87. Cyt vac - cytoplasmic vacuoles 
88. Dys EP - dyserythropoiesis 
89. P.Vx TPZ - P. Vivax Trophozoite
90. Meg EP - Megaloblastoid  Erythroid precursors 
91. BF - Band forms 
